Lebedeva IV - Search Results

1

Historical perspective and recent insights into our understanding of the molecular and biochemical basis of the antitumor properties of mda-7/IL-24.

Emdad L, Lebedeva IV, Su ZZ, Gupta P, Sauane M, Dash R, Grant S, Dent P, Curiel DT, Sarkar D, Fisher PB. Emdad L, et al. Among authors: lebedeva iv. Cancer Biol Ther. 2009 Mar;8(5):391-400. doi: 10.4161/cbt.8.5.7581. Epub 2009 Mar 8. Cancer Biol Ther. 2009. PMID: 19276652 Free article. Review.

2

mda-7 (IL-24): signaling and functional roles.

Sarkar D, Su ZZ, Lebedeva IV, Sauane M, Gopalkrishnan RV, Dent P, Fisher PB. Sarkar D, et al. Among authors: lebedeva iv. Biotechniques. 2002 Oct;Suppl:30-9. Biotechniques. 2002. PMID: 12395925

3

Restoring apoptosis as a strategy for cancer gene therapy: focus on p53 and mda-7.

Lebedeva IV, Su ZZ, Sarkar D, Fisher PB. Lebedeva IV, et al. Semin Cancer Biol. 2003 Apr;13(2):169-78. doi: 10.1016/s1044-579x(02)00134-7. Semin Cancer Biol. 2003. PMID: 12654260 Review.

4

mda-7/IL-24: exploiting cancer's Achilles' heel.

Lebedeva IV, Sauane M, Gopalkrishnan RV, Sarkar D, Su ZZ, Gupta P, Nemunaitis J, Cunningham C, Yacoub A, Dent P, Fisher PB. Lebedeva IV, et al. Mol Ther. 2005 Jan;11(1):4-18. doi: 10.1016/j.ymthe.2004.08.012. Mol Ther. 2005. PMID: 15585401 Free article. Review.

5

Unique aspects of mda-7/IL-24 antitumor bystander activity: establishing a role for secretion of MDA-7/IL-24 protein by normal cells.

Su Z, Emdad L, Sauane M, Lebedeva IV, Sarkar D, Gupta P, James CD, Randolph A, Valerie K, Walter MR, Dent P, Fisher PB. Su Z, et al. Among authors: lebedeva iv. Oncogene. 2005 Nov 17;24(51):7552-66. doi: 10.1038/sj.onc.1208911. Oncogene. 2005. PMID: 16044151

6

mda-7/IL-24: multifunctional cancer-specific apoptosis-inducing cytokine.

Gupta P, Su ZZ, Lebedeva IV, Sarkar D, Sauane M, Emdad L, Bachelor MA, Grant S, Curiel DT, Dent P, Fisher PB. Gupta P, et al. Among authors: lebedeva iv. Pharmacol Ther. 2006 Sep;111(3):596-628. doi: 10.1016/j.pharmthera.2005.11.005. Epub 2006 Feb 7. Pharmacol Ther. 2006. PMID: 16464504 Free PMC article. Review.

7

BiP/GRP78 is an intracellular target for MDA-7/IL-24 induction of cancer-specific apoptosis.

Gupta P, Walter MR, Su ZZ, Lebedeva IV, Emdad L, Randolph A, Valerie K, Sarkar D, Fisher PB. Gupta P, et al. Among authors: lebedeva iv. Cancer Res. 2006 Aug 15;66(16):8182-91. doi: 10.1158/0008-5472.CAN-06-0577. Cancer Res. 2006. PMID: 16912197

8

N-glycosylation of MDA-7/IL-24 is dispensable for tumor cell-specific apoptosis and "bystander" antitumor activity.

Sauane M, Gupta P, Lebedeva IV, Su ZZ, Sarkar D, Randolph A, Valerie K, Gopalkrishnan RV, Fisher PB. Sauane M, et al. Among authors: lebedeva iv. Cancer Res. 2006 Dec 15;66(24):11869-77. doi: 10.1158/0008-5472.CAN-06-1887. Cancer Res. 2006. PMID: 17178884

9

Melanoma differentiation associated gene-7/interleukin-24 (mda-7/IL-24): novel gene therapeutic for metastatic melanoma.

Fisher PB, Sarkar D, Lebedeva IV, Emdad L, Gupta P, Sauane M, Su ZZ, Grant S, Dent P, Curiel DT, Senzer N, Nemunaitis J. Fisher PB, et al. Among authors: lebedeva iv. Toxicol Appl Pharmacol. 2007 Nov 1;224(3):300-7. doi: 10.1016/j.taap.2006.11.021. Epub 2006 Nov 23. Toxicol Appl Pharmacol. 2007. PMID: 17208263 Free PMC article. Review.

10

Melanoma differentiation associated gene-7 (mda-7)/IL-24: a 'magic bullet' for cancer therapy?

Sarkar D, Lebedeva IV, Gupta P, Emdad L, Sauane M, Dent P, Curiel DT, Fisher PB. Sarkar D, et al. Among authors: lebedeva iv. Expert Opin Biol Ther. 2007 May;7(5):577-86. doi: 10.1517/14712598.7.5.577. Expert Opin Biol Ther. 2007. PMID: 17477796 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

104 results

Search Page

Filters